Advertisement
Advertisement
Trending on Dermatology Times
1
Rethinking Pathogenesis and Severity Assessment in Chronic Hand Eczema
2
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
3
Onboarding Your Atopic Dermatitis Patients With JAK Inhibitors
4
How Clinicians are Navigating JAK Inhibitors and Patient Expectations in Alopecia Areata
5
